Toggle light / dark theme

While renewable energy sources like wind and solar have become more common across the United States, fossil fuels remain the main source of energy. According to the U.S. Information Administration’s (EIA) International Energy Outlook 2021 (IEO2021), the global supply of fossil fuels and biofuels is expected to adequately meet global demands for liquid fuel through 2050. Renewable energy technologies have improved to become more efficient and less costly, however most renewable energies are unable to provide a constant supply of energy.

This issue inspired Shriya Tailor, a middle school student from Duluth, Georgia, to find a constant renewable energy supply that created energy at all hours of the day and in any weather condition.

She looked to space for this solution, leading her to design a prototype for a “Solar Energy Station.” Shriya says the station, made of solar cells, would need to be around 50 miles away from earth for the energy waves to be transmitted back to earth via electromagnetic fields, then collected by an antenna and converted back to electricity. Consisting of a small solar panel, switching circuit, and transmitting and receiving coils, Shriya’s prototype allowed her to test her process here on earth.

He’s backing a new biotech company working on “cellular rejuvenation programming.”


It sure looks like Jeff Bezos has plans to cheat death.

The founder and former CEO of Amazon has reportedly made an investment in the freshly launched Altos Labs, a biotech startup focused on “cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine,” according to a January 19 press release. With $3 billion in backing on day one, Altos Labs has hit the ground running with what may be the single largest funding round for a biotech company, according to the Financial Times of London.

Altos Labs has an impressive roster of executives that includes experts formerly of GlaxoSmithKline, a health care company in the United Kingdom that primarily develops pharmaceuticals and vaccines; Genentech, a San Francisco-based biotech firm that created the first targeted antibody for cancer; and the National Cancer Institute. The quest to cheat death is as old as life itself, but this is an especially pedigreed bunch to take on the challenge.

Researchers from Osaka University and Osaka City University synthesize and crystallize a molecule that is otherwise too unstable to fully study in the laboratory, and is a model of a revolutionary class of magnets.

Since the first reported production in 2004, researchers have been hard at work using graphene and similar carbon-based materials to revolutionize electronics, sports, and many other disciplines. Now, researchers from Japan have made a discovery that will advance the long-elusive field of nanographene magnets.

In a study recently published in Journal of the American Chemical Society, researchers from Osaka University and collaborating partners have synthesized a crystalline nanographene with magnetic properties that have been predicted theoretically since the 1950s, but until now have been unconfirmed experimentally except at extremely low temperatures.